Sulphasalazine and Derivatives, Natural Killer Activity and Ulcerative Colitis

Authors:

Abstract
The effects of sulfasalazine, 5-aminosalicylic acid (5-ASA), sulfapyridine and azodisalicylic acid (ADS) in vitro on the natural killer (NK) activity of peripheral blood mononuclear cells (MNC) were examined and compared with those of the lipoxygenase inhibitor, nordihydroguaiaretic acid (NDGA) and the cyclooxygenase inhibitor, indomethacin. Sulfasalazine, sulfapyridine and ADS inhibited NK activity with 50% inhibitory concentrations (IC50) of 0.7, 2.5 and 4.0 mmol/l respectively. The effect was rapidly reversible. 5-ASA minimally inhibited NK activity at 50 mmol/l only. NDGA potently inhibited NK activity (IC50 27 .mu.mol/l) but this was only partly reversible in short term incubations. Indomethacin had no effect at concentrations less than those inhibiting cyclooxygenase activity (1-10 .mu.mol/l) but potently and reversibly inhibited NK activity > 25 .mu.mol/l. The inhibitory effects observed were unlikely to be due to direct toxicity of effector cells as 5-ASA, sulfapyridine and ADS had no effect on the viability of peripheral blood MNC, whereas NDGA and indomethacin lysed MNC only at maximal concentrations tested. Though sulfasalazine produced MNC lysis > 1 mmol/l, the rapid reversibility of the inhibition of NK activity at 1 mmol/l suggested that lysis of NK cells contributed little to the suppressive effect at this concentration. The disparity of the therapeutic efficacy and effects on NK activity of sulfasalazine and its derivatives in vitro may suggest that NK activity is not a major pathogenic mechanism in ulcerative colitis. Any inhibitory effect on cellular immune function of indomethacin does not necessarily reflect an effect of cyclooxygenase inhibition.

This publication has 15 references indexed in Scilit: